Financhill
Back

BNY Mellon Ultra Short Income ETF Vs. MiNK Therapeutics, Inc. Industry Stock Comparison

Sell
38

BKUI
BNY Mellon Ultra Short Income ETF

Last Price:
$49.86
Seasonality Move:
0.14%
Sell
34

INKT
MiNK Therapeutics, Inc.

Last Price:
$11.91
Seasonality Move:
-18.07%
Sell
38
BNY Mellon Ultra Short Income ETF (BKUI) is a Sell

Is BNY Mellon Ultra Short Income ETF a Buy, Sell or Hold?

  • The current BNY Mellon Ultra Short Income ETF [BKUI] share price is $49.85. The Score for BKUI is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • BKUI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
MiNK Therapeutics, Inc. (INKT) is a Sell

Is MiNK Therapeutics, Inc. a Buy, Sell or Hold?

  • The current MiNK Therapeutics, Inc. [INKT] share price is $11.96. The Score for INKT is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • INKT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BKUI Stock Price Chart

What is BNY Mellon Ultra Short Income ETF's stock price today?

  • The BNY Mellon Ultra Short Income ETF share price today is $49.85
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BKUI is experiencing selling pressure, which indicates risk of future bearish movement.

INKT Stock Price Chart

What is MiNK Therapeutics, Inc.'s stock price today?

  • The MiNK Therapeutics, Inc. share price today is $11.96
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INKT is experiencing slight selling pressure.

BKUI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 55.1 Buy
Chaikin Money Flow: -3311 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.79 - 49.87) Buy
Bollinger Bands (100): (49.78 - 49.9) Buy

INKT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.13 Sell
Relative Strength Index (14 RSI): 47.65 Sell
Chaikin Money Flow: -11714 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.88 - 12.8) Buy
Bollinger Bands (100): (12.31 - 15.41) Sell

BKUI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 49.82 Buy
20-day SMA: 49.84 Buy
50-day SMA: 49.85 Buy
200-day SMA: 49.79 Buy
8-day EMA: 49.83 Buy
20-day EMA: 49.83 Buy
50-day EMA: 49.84 Buy
200-day EMA: 49.79 Buy

INKT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.29 Sell
20-day SMA: 11.54 Buy
50-day SMA: 12.98 Sell
200-day SMA: 11.84 Buy
8-day EMA: 12.15 Sell
20-day EMA: 12.09 Sell
50-day EMA: 12.72 Sell
200-day EMA: 12.23 Sell

BNY Mellon Ultra Short Income ETF Earnings Growth & BKUI Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

MiNK Therapeutics, Inc. Earnings Growth & INKT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and a decrease next year of $0.82 per share.

BNY Mellon Ultra Short Income ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

MiNK Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):